Contact
Please use this form to send email to PR contact of this press release:
Bragar Eagel & Squire, P.C. is Investigating Nabriva Therapeutics plc (NBRV) on Behalf of Stockholders and Encourages NBRV Investors to Contact the Firm
TO: